Exeltis Germany GmbH
- Legal form
- GmbH
- Seat
- Ismaning, Germany
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 27 March 2026.
Identifiers
As the covered sources state them.
- VAT ID
- DE270418798
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
No award found in the indexed notices of the last 36 months.
Awards
- GenerikaausschreibungBuyer: BARMER Beschaffung und Vergabe · Awarded: 27 March 2026 · CPV 33600000
- GenerikaausschreibungBuyer: BARMER Beschaffung und Vergabe · Awarded: 27 March 2026 · CPV 33600000
- GenerikaausschreibungBuyer: BARMER Beschaffung und Vergabe · Awarded: 27 March 2026 · CPV 33600000
- GenerikaausschreibungBuyer: BARMER Beschaffung und Vergabe · Awarded: 27 March 2026 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
Not found in the indexed notices.
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderSME (from the award notice)
Open house Arzneimittelrabattverträge Denosumab, ATC M05BX04
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 03:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open house Arzneimittelrabattverträge Golimumab, ATC L04AB06
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 04:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open house Arzneimittelrabattverträge Mesalazin, ATC A07EC02
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 04:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open house Arzneimittelrabattverträge Tocilizumab, ATC L04AC07
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 04:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open house Arzneimittelrabattverträge Erythropoietin, ATC B03AX01 (Kopie)
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 04:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open house Arzneimittelrabattverträge Ipratropiumbromid, ATC R03BB01
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 04:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open house Arzneimittelrabattverträge Treprostinil, ATC B01AC21
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 04:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bimekizumab, ATC L04AC21 für die Zeit 01.10.2026 - 31.03.2027
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 01:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus ausschließlich Wiesenlieschgraspollen, ATC V01AA02 für die Zeit 01.10.2026 - 31.10.2027
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 01:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Wiesenlieschgras, Ruchgras, etc., ATC V01AA02 für die Zeit 01.10.2026 - 30.09.2028
Reasons
- Won a contract in CPV group 336 (2026-03-27) Evidence · checked 9 Nov 2026
- 4 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 01:30 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 27 March 2026.